Physician profile
Daneca D Dipaolo
NPI 1851324784
$3,388.35
in general payments reported to CMS, 2019-2025
16 companies · $63.39 in 2025
The $63.39 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $1,832 · 2021: $750 · 2022: $15.39 · 2023: $164 · 2024: $447 · 2025: $63.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $1,805.79 | 2020 | |
| Arthrex, INC. | $479.00 | 2021 | |
| Acera Surgical, INC. | $285.31 | 2023-2025 | Restrata Wound Matrix |
| Gentleman Orthopedic Solutions | $240.13 | 2021 | |
| Sonex Health, INC. | $158.35 | 2024 | Sx-One Microknife |
| Endo USA, INC. | $144.57 | 2024 | Xiaflex |
| Conformis, INC. | $64.82 | 2019 | |
| Stryker Corporation | $50.20 | 2021-2025 | Hoffmann |
| Depuy Synthes Sales INC. | $34.12 | 2019 | |
| Amgen INC. | $30.74 | 2020-2025 | Evenity |
| Sanara Medtech INC. | $23.32 | 2023 | Celleraterx |
| Bioventus LLC | $17.32 | 2019 | |
| Abbvie INC. | $15.39 | 2022 | |
| Innovation Technologies INC | $15.27 | 2024 | Irrisept |
| Allergan, INC. | $12.28 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daneca Dipaolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.